Syngr1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
SYNGR1 encodes synaptogyrin-1, a major integral membrane component of synaptic vesicles. Synaptogyrin family proteins are involved in vesicle biogenesis, vesicle-pool organization, and the efficiency of neurotransmitter release under repetitive activity.[1][2] In neurons, SYNGR1 is part of a broader presynaptic module that includes Synaptophysin, VAMP2, RAB3A, and active-zone scaffolds such as RIM1.[2:1][3]
Although SYNGR1 is not among the highest-confidence Mendelian neurodegeneration genes, its biology sits in pathways that are repeatedly disrupted in Alzheimer's disease, Parkinson's disease, and related proteinopathy syndromes that feature early synaptic dysfunction.[4][5]
| Property | Value |
|---|---|
| Symbol | SYNGR1 |
| Full name | Synaptogyrin 1 |
| Chromosome | 22q12-q13 region |
| NCBI Gene | SYNGR1 Gene |
| OMIM | 603171 |
| Ensembl | ENSG00000185499 |
| Encoded protein | SYNGR1 Protein |
| Related pathways | Synaptic Vesicle Trafficking, Protein Aggregation |
SYNGR1 contributes to presynaptic function through membrane-level vesicle control rather than catalytic signaling.[1:1][2:2]
These effects are strongest in fast-spiking and highly active neuronal circuits where vesicle turnover capacity determines information throughput.[2:5][3:2]
A key feature of Alzheimer's disease is early synaptic compromise before substantial neuronal loss.[4:1][5:1] Because SYNGR1 is embedded in presynaptic vesicle machinery, altered abundance or stoichiometry of synaptogyrin-containing vesicles is interpreted as part of this early synapse pathology signature.[4:2][5:2]
In Parkinson's disease, presynaptic vesicle handling and alpha-synuclein stress are tightly linked.[7][8] SYNGR1 is mechanistically relevant because perturbations in vesicle membrane proteins can shift dopamine terminal resilience and recycling capacity under stress.[7:1][8:1]
For ALS and frontotemporal dementia, synaptic dysfunction and altered RNA/protein homeostasis intersect with vesicle biology.[9] SYNGR1 is best viewed as a pathway component that can report or modify presynaptic state in vulnerable motor and cortical circuits.[9:1]
SYNGR1 is useful for presynaptic phenotyping in disease models:
The study of Syngr1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Hubler D, Rankovic M, Richter K, et al. Differential expression of synaptogyrins and synaptophysin in the adult rat central nervous system. J Mol Neurosci. 2004. ↩︎ ↩︎ ↩︎
Takamori S, Holt M, Stenius K, et al. Molecular anatomy of a trafficking organelle. Cell. 2006. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Sudhof TC. Neurotransmitter release: the last millisecond in the life of a synaptic vesicle. Neuron. 2004. ↩︎ ↩︎ ↩︎
Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002. ↩︎ ↩︎ ↩︎ ↩︎
de Wilde MC, Overk CR, Sijben JW, Masliah E. Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability. Alzheimers Dement. 2016. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Kwon SE, Chapman ER. Synaptophysin regulates the kinetics of synaptic vesicle endocytosis in central neurons. Neuron. 2011. ↩︎
Bendor JT, Logan TP, Edwards RH. The function of alpha-synuclein. Neuron. 2013. ↩︎ ↩︎
Bridi JC, Hirth F. Mechanisms of alpha-synuclein induced synaptopathy in Parkinson's disease. Front Neurosci. 2018. ↩︎ ↩︎
Fogarty MJ. Driven to decay: excitability and synaptic abnormalities in amyotrophic lateral sclerosis. Brain Res Bull. 2019. ↩︎ ↩︎